Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Antoni Sicras-Mainar, Javier Rejas-Gutiérrez, María Pérez-Paramo, Luis Sánchez-Alvarez, Ruth Navarro-Artieda & Josep Darbà. (2019) Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin. Expert Review of Pharmacoeconomics & Outcomes Research 19:1, pages 45-57.
Read now
Read now
Pierre Blier, Howard C. Margolese, E Adriana Wilson & Matthieu Boucher. (2019) Switching medication products during the treatment of psychiatric illness. International Journal of Psychiatry in Clinical Practice 23:1, pages 2-13.
Read now
Read now
David B Price, Eran Gefen, Gokul Gopalan, Cristiana Miglio, Rosie McDonald, Vicky Thomas & Simon Wan Yau Ming. (2017) Real-life effectiveness and safety of the inhalation suspension budesonide comparator vs the originator product for the treatment of patients with asthma: a historical cohort study using a US health claims database. Pragmatic and Observational Research 8, pages 69-83.
Read now
Read now